RESEARCH TRIANGLE PARK, NC – IQVIA™ (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, announced that Marie… Read More
Six posters highlight continued progress across antibody-drug conjugate and T cell engager platforms Novel T cell engager ZW209 demonstrates durable activity in small cell lung cancer; IND submission expected in… Read More
EDMONTON, AB – The Alberta Cancer Foundation and Hoffmann-La Roche Limited (Roche Canada) have announced a new partnership that will see the global life sciences company redirect $1 million of its… Read More
VANCOUVER, BC — Kardium Inc., a private medical device company that’s advancing the way the world treats atrial fibrillation (AF), announced late-breaking, one-year clinical trial results for its innovative pulsed… Read More
Augurex to attend British Society for Rheumatology 2025 Annual Meeting in Manchester, UK Highlighting biomarker-based diagnostic innovations for RA and axSpA VANCOUVER, BC – Augurex Life Sciences Corp., a leader… Read More
